Carlucci Annalisa, Ceriana Piero, Mancini Marco, Cirio Serena, Pierucci Paola, D'Artavilla Lupo Nadia, Gadaleta Felice, Morrone Elisa, Fanfulla Francesco
Pulmonary Rehabilitation, Fondazione Salvatore Maugeri IRCCS - Scientific Institute of Pavia, Pavia, Italy.
Department of Thoracic Medicine, St. Vincent's Hospital, Darlinghurst NSW, Australia.
J Clin Sleep Med. 2015 Sep 15;11(9):981-5. doi: 10.5664/jcsm.5008.
Ventilation with continuous positive airway pressure (CPAP) is the gold standard therapy for obstructive sleep apnea (OSA). However, it was recently suggested that a novel mode of ventilation, Bilevel-auto, could be equally effective in treating patients unable to tolerate CPAP. The aim of this study was to investigate the ability of Bilevel-auto to treat OSA patients whose nocturnal ventilatory disturbances are not completely corrected by CPAP.
We enrolled 66 consecutive OSA patients, not responsive to (group A) or intolerant of (group B) CPAP treatment, after a full night of manual CPAP titration in a laboratory. Full polysomnography data and daytime sleepiness score were compared for each group in the three different conditions: basal, during CPAP, and during Bilevel-auto.
The apnea-hypopnea index decreased significantly during CPAP in both groups; however, in the group A, there was a further significant improvement during Bilevel-auto. The same trend was observed for oxygenation indices, while the distribution and the efficiency of sleep did not differ following the switch from CPAP to Bilevel-auto.
This study confirmed the role of Bilevel-auto as an effective therapeutic alternative to CPAP in patients intolerant of this latter mode of ventilation. Moreover, extending the use of Bilevel-auto to those OSA patients not responsive to CPAP, we showed a significantly better correction of nocturnal respiratory disturbances.
持续气道正压通气(CPAP)是阻塞性睡眠呼吸暂停(OSA)的金标准治疗方法。然而,最近有研究表明,一种新型通气模式——双水平自动通气,在治疗无法耐受CPAP的患者时可能同样有效。本研究的目的是调查双水平自动通气治疗夜间通气障碍未被CPAP完全纠正的OSA患者的能力。
我们招募了66例连续的OSA患者,这些患者在实验室经过一整夜的手动CPAP滴定后,对CPAP治疗无反应(A组)或不耐受(B组)。比较了每组在三种不同条件下的全夜多导睡眠图数据和日间嗜睡评分:基础状态、CPAP治疗期间和双水平自动通气治疗期间。
两组患者在CPAP治疗期间呼吸暂停低通气指数均显著降低;然而,在A组中,双水平自动通气治疗期间有进一步的显著改善。氧合指数也观察到相同的趋势,而从CPAP转换为双水平自动通气后,睡眠的分布和效率没有差异。
本研究证实了双水平自动通气作为CPAP不耐受患者有效治疗替代方案的作用。此外,将双水平自动通气的使用扩展到对CPAP无反应的OSA患者中,我们发现夜间呼吸障碍的纠正效果明显更好。